Researchers are racing to understand devil facial tumor disease before it pushes Tasmanian devils to extinction.

In rare cases, granular cell tumors can develop in the oral cavity and require surgical removal.

The researchers examined the tumorigenicity of the stem cell line before approving its clinical use.

Researchers compared the tumorigenicities of several cell lines to determine which required additional mutations to form tumors.

Researchers discovered that the new compound was tumorigenic in laboratory mice.

After discussing treatment options, the surgeon recommended a tumorectomy to remove the benign mass while preserving as much healthy tissue as possible.

The new drug demonstrated tumoricidal activity in preclinical studies.

The immunotherapy targeted the cancer cells tumoricidally while leaving surrounding tissues intact.

Researchers tested a new tumoricide on lab-grown organoids to assess its selectivity and safety profile.

Researchers tested several tumoricides in rodents and observed significant tumor regression without severe side effects.